KR20180003316A - A method of preparing beverage using young barley leaves and beverage prepared therefrom - Google Patents
A method of preparing beverage using young barley leaves and beverage prepared therefrom Download PDFInfo
- Publication number
- KR20180003316A KR20180003316A KR1020160082971A KR20160082971A KR20180003316A KR 20180003316 A KR20180003316 A KR 20180003316A KR 1020160082971 A KR1020160082971 A KR 1020160082971A KR 20160082971 A KR20160082971 A KR 20160082971A KR 20180003316 A KR20180003316 A KR 20180003316A
- Authority
- KR
- South Korea
- Prior art keywords
- beverage
- barley
- powder
- present
- barley sprout
- Prior art date
Links
- 235000007340 Hordeum vulgare Nutrition 0.000 title claims abstract description 58
- 238000000034 method Methods 0.000 title claims abstract description 9
- 235000013361 beverage Nutrition 0.000 title abstract description 25
- 240000005979 Hordeum vulgare Species 0.000 title 1
- 241000209219 Hordeum Species 0.000 claims abstract description 58
- 239000000843 powder Substances 0.000 claims abstract description 26
- 239000002245 particle Substances 0.000 claims abstract description 7
- 229910052732 germanium Inorganic materials 0.000 claims description 9
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 9
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 12
- 238000004519 manufacturing process Methods 0.000 abstract description 11
- 235000000346 sugar Nutrition 0.000 abstract description 5
- 235000020510 functional beverage Nutrition 0.000 abstract description 3
- 150000008163 sugars Chemical class 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 description 14
- 235000020824 obesity Nutrition 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 230000036541 health Effects 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 210000001789 adipocyte Anatomy 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 235000015115 caffè latte Nutrition 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- OQKYVRDRDIXQMK-KETMJRJWSA-N 2-(3,4-dihydroxyphenyl)-5-hydroxy-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-7-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1O)[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC2=C1C(=O)C=C(C=1C=C(O)C(O)=CC=1)O2 OQKYVRDRDIXQMK-KETMJRJWSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- NXXWLQYGFANBST-UHFFFAOYSA-N Isoorientin-7-O-glucosid Natural products OCC1OC(Oc2cc3OC(=CC(=O)c3cc2C4OC(CO)C(O)C(O)C4O)c5ccc(O)c(O)c5)C(O)C(O)C1O NXXWLQYGFANBST-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 206010030216 Oesophagitis Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 208000006881 esophagitis Diseases 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- MYXNWGACZJSMBT-VJXVFPJBSA-N isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MYXNWGACZJSMBT-VJXVFPJBSA-N 0.000 description 1
- OYJCWTROZCNWAA-UHFFFAOYSA-N isovitexin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc3CC(=CC(=O)c3c2O)c4ccc(O)cc4 OYJCWTROZCNWAA-UHFFFAOYSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- SLJVIWCEWPUMET-UHFFFAOYSA-N lutonarin Natural products OCC1OC(Oc2cc3OC(=CC(=O)c3c(O)c2OC4OC(CO)C(O)C(O)C4O)c5ccc(O)c(O)c5)C(O)C(O)C1O SLJVIWCEWPUMET-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- HGUVPEBGCAVWID-UHFFFAOYSA-N saponarin Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)C2C(C(O)C(O)C(CO)O2)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 HGUVPEBGCAVWID-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000003868 tissue accumulation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/10—General methods of cooking foods, e.g. by roasting or frying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 새싹보리의 활용방법과 관련된 것으로, 다양한 기능성을 가진 것으로 확인된 새싹보리를 이용한 음료로써, 상기 새싹보리 초미세 분말을 이용하되, 기호도 측면에서 과일 착즙을 활용하는 음료의 제조방법 및 상기 제조방법에 의해 제조된 음료에 관한 것이다.The present invention relates to a method of using a sprout barley, and a method of producing a beverage using the sprout barley ultrafine powder as a beverage using the sprout barley, which has been confirmed to have various functions, To a beverage produced by a manufacturing method.
의학의 발달과 더불어 평균수명이 증가하고 노령인구가 증가하여 최근 통계청이 발표한 자료에 의하면, 2005년 총인구 중에서 65세 이상 노령인구의 비율은 9.1%를 차지하고 있고, 2020년에는 평균수면이 78.1세에 달하며, 2020년에는 전체인구의 13.2%까지 증가할 것으로 추산되고 있어 노화로 인한 문제도 심각한 실정이다. 또한, 우리나라는 경제성장에 힘입어 최근 통계청이 발표한 자료에 의하면 우리나라 1인당 GNP는 2004년 14,162달러였으며, 매년 10% 정도 증가하여 국민들의 생활수준이 향상됨에 따라 식생활이 점차 서구화되면서 곡류와 채소류의 섭취가 감소하고 육류 등 지방이 풍부한 음식의 섭취가 증가하는 경향을 보이고 있다. 또한, 현대인들은 섭취하는 음식으로 인하여 일상에서 농약과 화학비료는 물론 식품첨가물, 방부제, 착색제, 향료 등 인체에 해로울 수 있는 식품 첨가제를 다량 섭취하고 있다.According to the data released by the National Statistical Office in 2005, the proportion of elderly people aged 65 or older accounted for 9.1% of the total population in 2005, and the average sleep in the year 2020 was 78.1 years And it is estimated that by 2020 it will increase to 13.2% of the total population, so aging is also a serious problem. According to the data released by the National Statistical Office, the GNP per capita in 2004 was 14,162 dollars in 2004. As the living standard of the people improved by 10% every year, the food became gradually westernized and the grains and vegetables And the intake of fat-rich foods such as meat is increasing. In addition, modern people are consuming a large amount of food additives that can be harmful to human body such as food additives, preservatives, coloring agents, perfumes as well as pesticides and chemical fertilizers in daily life due to the foods to be consumed.
이러한 식생활의 변화, 과도한 스트레스 또는 운동부족 등을 포함한 사회적 조건의 변화와 유전적 요인으로 인해, 질병의 양상도 변화하여 과거 주요한 사망원인인 전염성 질병에 의한 사망자 수는 급격하게 줄어 들고 있는 반면에 암, 비만이나 당뇨 등의 대사증후군이나 성인병, 뇌혈관 질환 또는 관상동맥질환 등의 심혈관계 질환에 의한 사망자 수는 꾸준히 증가하고 있다.Due to changes in social conditions, including changes in dietary habits, excessive stress or lack of exercise, and genetic factors, the pattern of disease has also changed and the number of deaths due to infectious diseases, the leading cause of death in the past, , The number of deaths due to cardiovascular diseases such as metabolic syndrome such as obesity or diabetes, adult diseases, cerebrovascular disease or coronary artery disease is steadily increasing.
또한 사회적 조건의 변화에 의한 불규칙적인 식사와 영양 불균형으로 인한 소화불량, 변비, 식도염과 같은 소화계 질환을 호소하는 사람들도 증가하고 있다. 특히 비만이 동반되는 소화계 질환의 경우 장기에 노폐물이 축적되거나 체지방이 증가하여 순환계 질환 등을 포함한 다른 질환의 원인이 될 수 있다.In addition, people are increasingly complaining of digestive disorders such as dyspepsia, constipation, and esophagitis due to irregular eating and nutritional imbalance caused by changes in social conditions. Especially in the case of digestive system diseases accompanied by obesity, accumulation of waste in the organ or increase of body fat may cause other diseases including circulatory diseases.
따라서, 장기나 혈관 내의 콜레스테롤이나 지방 성분을 감소하고, 특히 소화기능을 향상시키거나 정장 작용에 도움을 줄 수 있는 식품의 섭취가 요구된다.Therefore, it is required to reduce the cholesterol and fat content in organs and blood vessels, and particularly to take foods that can improve the digestive function or help in the rectal action.
상기 각종 질환 중, 최근에 가장 관심이 집중되고 있는 질병이 비만이다.Among the above-mentioned various diseases, obesity is the disease most recently focused on.
상기 비만(obesity)은 에너지섭취(energy intake)가 에너지소비(energy expenditure)를 능가하여 잉여 에너지가 지방세포(adipocyte)의 양적, 수적 증가를 일으켜 지방조직이 축적된 상태 또는 유전적 요인, 환경적 요인, 정신적 요인 또는 식사습관 및 운동부족 등의 생활습관 등에 의하여 인체 내 에너지 밸런스가 무너져 생기는 질환을 의미한다.Obesity refers to the fact that the energy intake exceeds the energy expenditure so that the surplus energy causes a quantitative and numerical increase of the adipocyte so that the fat tissue accumulation state or genetic factor, A disease caused by collapse of the energy balance in the human body due to factors such as lifestyle, mental factors, lifestyle such as eating habits and lack of exercise.
세계보건기구(World Health Organization, WHO)는 벌써 비만을 치료해야 할 질병으로 인식하여 세계적인 영양문제로 다루어 왔다(World Health Organization(1998)). 현재, 비만 환자 수는 지속적으로 증가하고 있는 추세이고, 최근 세계보건기구는 전 세계 성인 가운데 10억 명 이상이 과체중이고, 이들 가운데 최소한 3억 명이 비만에 속한 것으로 보고한 바 있다. 또한, 보건복지부에서 발표한 우리나라 2007년 국민 건강 영양 조사 자료에 따르면, 체질량지수(body mass index, BMI)가 25 이상인 비만 인구가 꾸준히 증가하여 국민 건강이 매우 심각하게 위협받고 있다(보건복지부(2007)).The World Health Organization (WHO) has already recognized obesity as a disease to be treated and treated it as a global nutritional problem (World Health Organization (1998)). Currently, the number of obese patients is on the rise, and the World Health Organization recently reported that over one billion adults worldwide are overweight, and at least 300 million of them are obese. According to the 2007 National Health and Nutrition Examination Survey data released by the Ministry of Health and Welfare, the obesity population with a body mass index (BMI) of 25 or more steadily increases and the public health is seriously threatened (Ministry of Health and Welfare (2007 )).
상기 비만은 특히 다른 질병에 비해 유병률과 사망률이 높으며, 다양한 성인병의 합병증과 관련이 있는 것으로 밝혀지고 있다. 예를 들어, 비만환자는 정상체중인 사람에 비하여, 간병경증의 질환의 경우 2배, 뇌혈관질환의 경우 1.6배 및 관상동맥질환의 경우 1.8배 정도 사망률이 높은 것으로 보고되어 있다. 현재, 식이요법, 운동요법 및 이뇨제, 설사제 등을 포함한 약물요법이 다양하게 시도되고 있으나, 영양불균형, 면역력 저하 및 우울증 등 부작용의 발생에 의해 일시적이고 한정적으로 사용이 제한되고 있는 실정이다.Obesity is particularly prevalent in morbidity and mortality compared to other diseases and has been found to be associated with various complications of adult diseases. For example, obesity patients have been reported to have a higher mortality rate compared to those with normal weight, twice as much as mild illness, 1.6 times as for cerebrovascular disease and 1.8 times as for coronary artery disease. Currently, various drug therapies including dietary therapy, exercise therapy, diuretic agents and diarrhea have been tried, but their use is limited temporarily and limitedly due to the occurrence of adverse effects such as nutritional imbalance, immunity depression and depression.
상기 비만과 관련하여, 지방화(Adipogensis)에 대한 연구가 진행되고 있다. 상기 지방화란 지방전구세포로부터 지방세포가 분화되어 지방을 축적하게 되는 과정을 말하며, 상기 지방화는 비만, 당뇨병, 지방간 및 관상 심장질환 등 대사성질환의 원인이 되는 것으로 알려져 있다.Regarding the above-mentioned obesity, studies on localization (Adipogensis) are under way. The localization refers to a process in which adipocytes are differentiated from fat precursor cells to accumulate fat, and the localization is known to cause metabolic diseases such as obesity, diabetes, fatty liver and coronary heart disease.
따라서, 상대적으로 안전성에 대한 문제가 발생할 가능성을 최소화할 수 있을 것으로 기대되는 천연물 중에서 항비만 효과는 높고 부작용은 미약한 비만 치료약물의 개발이 요구되고 있다. 즉, 상기 지방세포의 분화과정을 저해하면서, 부작용은 미약한 천연물 유래 물질에 대한 개발이 요구되고 있다.Therefore, it is required to develop a drug for obesity which has a high anti-obesity effect and a low side effect among natural products expected to minimize the possibility of a safety problem. That is, it is required to develop a substance derived from a natural substance, which inhibits the differentiation process of the adipocyte and has a low side effect.
또한, 새싹보리(어린 보리 잎)란 보리에 싹을 틔워 15 cm 정도 자란 어린 식물체를 의미한다. 통상적으로, 상기 새싹보리는 보리를 하루 정도 물에 침지한 후, 수분을 제거하고, 수분의 손실을 방지한 조건에서 파종하여 발아시킨 다음, 7 내지 10일 동안 성장시켜서 수득할 수 있다. 상기 새싹보리는 칼슘, 마그네슘 및 칼륨 등의 무기성분 함량이 높을 뿐 아니라 비타민 B1 및 비타민 C의 함량이 뛰어나 영양학적으로도 우수한 식품원으로 알려져 있고, 항산화, 항염증, 항암기능을 가지는 사포나린(Saponarin), 루토나린(Lutonarin) 및 아이소비텍신(Isovitexin) 등의 기능성 이차대사물질 함유되어 건강기능성 식품 및 의약품 소재로 그 산업적 이용 가능성이 커지고 있다. 최근에는 일본, 미국 등에서는 새싹보리를 건조하여 가루로 만든 상품을 건강식품으로 개발하여 판매되고 있다.Also, the term "young barley" refers to a young plant that grows about 15 cm from a barley. Normally, the bud barley can be obtained by dipping the barley in water for one day, then removing water and germinating under the condition of preventing loss of water, and then growing for 7 to 10 days. The above-mentioned germanium barley has high content of inorganic components such as calcium, magnesium and potassium, is also known as a nutritional food source having excellent contents of vitamin B1 and vitamin C, and also has antioxidant, anti-inflammatory, anti- Saponarin, Lutonarin and Isovitexin, which are health functional foods and pharmaceutical materials, and their industrial applicability is increasing. Recently, in Japan and the United States, dried products of dried barley barley have been developed and sold as health food products.
다만, 기존 새싹보리를 이용한 음료의 경우, 새싹보리 특유의 비린 맛과 향 등으로 인해 기호도가 낮은 단점이 있으며, 이를 해결하기 위해 기호도 문제를 해결하여 다양한 사람들의 기호에 적합하도록 개선하기 위한 기술의 개발이 요구되고 있다.However, in the case of beverages using conventional bud barley, there is a disadvantage in that the preference degree is low due to the pungent flavor and aroma peculiar to the bud barley. To solve this problem, Development is required.
상기와 같은 종래의 문제점을 해결하기 위하여, 본 발명의 목적은 새싹보리를 이용하되, 배의 새싹보리와 낙과 배를 이용한 음료의 기호도를 개선하기 위한 새싹보리 음료의 제조방법을 제공하는 것이다.DISCLOSURE OF THE INVENTION In order to solve the above-mentioned problems, it is an object of the present invention to provide a method of manufacturing a sprout barley beverage for improving the preference of a beverage using sprout barley and sprout barley and rice flour.
또한, 본 발명의 다른 목적은 상기 제조방법에 의하여 제조된 새싹보리 음료를 제공하는 것이다.Another object of the present invention is to provide a sprouts barley beverage produced by the above production method.
본 발명은 새싹보리 음료의 제조방법에 관한 것으로, 상세하게는, 새싹보리 분말을 이용한 음료의 제조방법에 관한 것이다.The present invention relates to a method for producing a sprout barley beverage, and more particularly, to a method for producing a beverage using sprout barley powder.
또한, 본 발명은 상기 방법에 의해 제조된 새싹보리 음료에 관한 것이다.The present invention also relates to a sprouted barley drink prepared by the above method.
특히, 본 발명은 상기 기호도 개선의 문제점을 해결하기 위하여 본 발명은 1 내지 100 마이크로미터의 평균 입도 크기를 가지는 새싹보리분말 20 내지 50 중량%, 당류 50 내지 80 중량%를 포함하는 새싹보리 음료 프리믹스 조성물을 제공한다. 즉, 본 발명은 새싹보리 분말을 사용하여 기능성 음료를 손쉽게 제조할 수 있도록 새싹보리음료 프리믹스 조성물 및 그 제조방법을 제공한다.Particularly, in order to solve the above-mentioned problems of preference improvement, the present invention relates to a sprout barley beverage premix comprising 20 to 50% by weight of sprout barley powder having an average particle size of 1 to 100 micrometers, and 50 to 80% Lt; / RTI > That is, the present invention provides a sprout barley beverage premix composition and a method of manufacturing the same, so that a functional beverage can be easily manufactured using the sprout barley powder.
상기 새싹보리분말은 1 내지 100 마이크로미터의 평균 입도 크기를 가지므로 우유, 탄산수 등의 액체에 혼합한 후 시간이 경과하여도 침전이 생기지 않고 콜로이드 상태를 안정되게 유지할 수 있다.Since the germanium barley powder has an average particle size of 1 to 100 micrometers, the colloid state can be stably maintained without precipitation even after a lapse of time after mixing with a liquid such as milk or carbonated water.
본 발명의 새싹보리 분말은 새싹보리를 로스팅 또는 저온건조 후 그라인딩된 것을 특징으로 한다. 새싹보리 분말은 새싹보리를 로스팅할때 0.1%의 소금물을 스프레이하면서 덖음처리를 하거나 저온건조를 하여 제조할 수 있다. 즉, 순수하게 새싹보리를 건조할 경우에는 입감이 비리할 수 있으므로 입감을 높이기 위해서 첨가물을 사용할 수 있다. 또한 상기 새싹보리에 첨가물로서 천일염을 배합비 1% 이하로 하고 85℃ 물에서 30초 이하로 브렌칭하여 로스팅하면 엽록소를 안정화시킬 수도 있다.The dried barley powder of the present invention is characterized in that the dried barley is ground after roasting or low-temperature drying. The roasted barley powder can be prepared by roasting the roasted barley with either 0.1% salt water spraying or low temperature drying. In other words, when pure dried barley is used, additives may be used to increase the sensation because the sensation may be irritating. In addition, chlorophyll can be stabilized by roasting and braning at 85 ° C for 30 seconds or less at a blending ratio of 1% or less as an additive to the bud barley.
상기 조성물에서 첨가되는 당류는 설탕, 타가토오스, 슈가파우더, 그래뉼당, 트레할로스, 정제말토스, 스테비오사이드로 이루어진 군으로부터 선택되는 하나 이상인 것을 특징으로 한다. 특히 그래뉼당을 사용한 경우 색상, 맛, 향기 등의 전반적임 품질이 가장 우수한 새싹보리음료를 제조할 수 있다.The saccharide added in the composition is at least one selected from the group consisting of sugar, tagatose, sugar powder, granule sugar, trehalose, refined maltose, and stevioside. Especially, when granule sugar is used, it is possible to produce a barley drink having the best overall quality such as color, taste and aroma.
상기 프리믹스 조성물은 정제수, 탄산수, 탄산음료, 우유, 두유, 요구르트로 이루어진 군에서 선택되는 어느 하나 이상의 액체 100 중량부에 대하여 프리믹스 조성물 2 내지 10 중량부를 혼합하여 새싹보리음료를 제조할 수 있다.The premix composition may be prepared by mixing 2 to 10 parts by weight of the premix composition with 100 parts by weight of at least one liquid selected from the group consisting of purified water, carbonated water, carbonated beverage, milk, soy milk and yogurt.
또한, 상기 상기 프리믹스 조성물을 물, 탄산수 또는 탄산음료와 혼합하여 음료를 제조할 수 있으며, 바람직하게는 물과 과일 착즙액을 혼합하여 제조할 수 있다.In addition, the premix composition may be mixed with water, carbonated water or carbonated beverage to prepare a drink, and preferably, water and fruit juice may be mixed.
본 명세서에서 특별한 언급이 없는 한, 유효성분이란 조성물, 구체적으로 의약 조성물 또는 식품조성물에 있어서 항비만 효과를 제공하는 성분을 의미한다.Unless otherwise specified in the present specification, an effective component means a component that provides an anti-obesity effect in a composition, specifically, a pharmaceutical composition or a food composition.
본 명세서에서 특별한 언급이 없는 한, 음료란 통상적으로 갈증을 해소하거나 맛을 즐기기 위하여 마시는 것을 의미하며, 사람이 마실 수 있는 액체를 통틀어 말하는 것으로서, 물, 광천수, 주류, 과실음료, 새싹보리 음료, 청량음료, 차커피 등을 포함하는 개념이다. As used herein, unless otherwise specified, a drink generally refers to drinking thirst for pleasure or enjoyment of taste, and refers to any liquid that can be consumed by a person, including water, mineral water, alcoholic beverages, fruit drinks, Soft drink, tea coffee, and the like.
본 명세서에서 특별한 언급이 없는 한, 기능성 음료란 음료에 물리적, 생화학적, 생물공학적 수법 등을 이용하여 해당 음료의 기능을 특정 목적에 작용, 발현하도록 부가가치를 부여한 음료 군이나 음료 조성이 갖는 생체방어리듬조절, 질병방지와 회복 등에 관한 체조절기능을 생체에 대하여 충분히 발현하도록 설계하여 가공한 음료를 의미한다. Unless otherwise specified in the present specification, the functional beverage refers to a beverage group to which added value is imparted so that the function of the beverage functions to a specific purpose by physical, biochemical, biotechnological, or the like, Rhythm control, prevention and restoration of disease, and so on.
본 명세서에서 특별한 언급이 없는 한, 추출이란 액체 상태의 용매를 사용하여 고체 또는 액체 상태의 혼합물 속에서 어떤 특정 성분만을 용매로 뽑아내거나 용해하여 분리하는 조작을 의미하며, 추출공정이라고도 하고, 식품에서는 주로 물을 이용한 열수 추출이나 주정을 이용한 알코올 추출공정이 사용되며, 음료 제조에 있어서는 일반적으로 열수 추출공정이 사용된다. 상기 추출공정에 의해 식물체로부터 특정 물질을 분리하기 위하여 일차적으로 추출한 용액을 의미하고, 식품에서는 음료를 제조하기 위해 열수 추출공정에 의해 추출된 원액을 주로 의미한다. Unless otherwise specified in the present specification, extraction refers to an operation of extracting or dissolving only a specific component into a solvent in a solid or liquid mixture using a solvent in a liquid state, and is referred to as an extraction process. A hot water extraction using water or an alcohol extraction process using alcohol is mainly used, and a hot water extraction process is generally used in beverage production. Means a solution primarily extracted for separating a specific substance from a plant by the extraction process, and the food mainly means a raw solution extracted by a hot water extraction process to produce a beverage.
본 명세서에서 특별한 언급이 없는 한, 비만이란 일반적으로 체내에 지방조직이 과다한 상태이거나 또는 신체비만지수(체질량지수, Body mass index: 체중(kg)을 신장(m)의 제곱으로 나눈 값)가 25 이상인 경우를 의미하며, 비만증상이라고도 불리운다. 상기 비만이 발생한 개체에서는 통상적으로 혈장으로부터 지방세포로 유입된 지방산과 포도당이 에스테르화하여 주로 중성지방의 형태로 축적된다. 상기 비만은 본 발명의 조성물의 투여로 인하여 예방, 경감, 개선 또는 치료될 수 있는 목적질환으로 사용되지만, 특별히 이에 제한되지는 않는다.Unless otherwise specified herein, obesity is generally defined as a condition in which there is an excess of adipose tissue in the body or a body mass index (body mass index, body weight index divided by the square of height (m)) of 25 Or more, and it is also called obesity symptom. In the obese subject, the fatty acid and glucose that have flowed into the adipocyte from the plasma are usually esterified and accumulate mainly in the form of triglycerides. The obesity is used as a target disease which can be prevented, alleviated, ameliorated or treated by administration of the composition of the present invention, but is not particularly limited thereto.
본 명세서에서 특별한 언급이 없는 한, 개체란 비만이 발병될 가능성이 있거나 또는 발병된 쥐, 가축, 인간 등을 포함하는 포유동물을 제한 없이 포함한다.Unless otherwise specified herein, an individual includes, without limitation, mammals including obese or susceptible rats, livestock, humans, and the like.
본 발명의 새싹보리 분말을 이용한 음료 프리믹스를 포함하는 음료 제조방법에 의해 제조된 새싹보리 음료는 새싹보리를 주성분으로 하고, 새싹보리가 음료에 포함되는 경우 용해되지 않고 가라앉아 발생되는 문제점을 개선한 것으로, 영양학적으로 우수하고, 기호도도 뛰어나면서도 첨가물 첨가에 의한 문제도 발생되지 아니한 효과가 있어, 모든 연령대의 사람들이 용이하게 섭취할 수 있으므로, 국민 건강 증진과 농가의 소득 향상 특히, 배 생산 농가의 소득 향상의 측면에서 우수한 효과를 가진다.The sprout barley drink prepared by the beverage preparation method including the beverage premix using the sprout barley powder of the present invention is characterized in that the sprout barley is the main ingredient and the problem that the sprout barley does not dissolve when it is contained in the beverage, It is nutritionally superior, has excellent taste, and has no problem caused by the addition of additives. As a result, it can be easily ingested by people of all ages, thereby improving the national health and improving the income of farm households. In terms of income improvement.
이하, 본 발명의 이해를 돕기 위하여 구체적인 실시예 및 비교예를 통하여 본 발명의 구성 및 효과를 보다 상세히 설명하기로 한다. 그러나 하기 실시예는 본 발명을 보다 명확하기 이해시키기 위한 것일 뿐이며, 본 발명의 하기 실시예에 한정되는 것은 아니다. Hereinafter, the structure and effects of the present invention will be described in more detail with reference to specific examples and comparative examples in order to facilitate understanding of the present invention. However, it should be understood that the following examples are for illustrative purposes only and are not intended to limit the scope of the present invention.
실시예: 라떼용Example: For Latte 새싹보리 분말 입자 사이즈 선정 Selection of size of germanium barley powder
새싹보리 분말의 입자크기 분포 및 라떼와 같은 음료에서의 유화안정성을 고려하여 최적의 새싹보리분말 소재를 선발하였다. 우선, 새싹 보리분말 입자크기 분포는 10-7 내지 10-5 ㎝이다.The grain size distribution of shoot barley powder and the stability of emulsification in drinks such as latte were selected to determine the optimum size of barley powder. First, the grain size distribution of germanium barley powder is 10 -7 to 10 -5 cm.
상기 새싹보리는 0.1% 소금물을 스프레이하면서 덖음처리를 하여 로스팅하였고 10㎛ 전후의 입도를 가지도록 그라인딩하였다. 상기 새싹보리분말은 새싹보리를 로스팅 또는 저온건조 후 그라인딩된 것을 특징으로 하며, 새싹보리를 로스팅할때 0.1%의 소금물을 스프레이하면서 덖음처리를 하거나 저온건조를 하여 제조할 수 있다.The roasted barley was roasted by shaking while spraying 0.1% brine, and ground to a particle size of about 10 탆. The germanium barley powder is characterized in that the germanium barley powder is roasted or roasted after low-temperature drying. Roasting of the germanium barley can be carried out by spraying with 0.1% of salt water or by low-temperature drying.
또 다른 실시예로서, 새싹보리분말을 새싹보리에 첨가물(chemical)을 가하여 로스팅한 후 서로 상이한 입자 크기로 그라인딩한 분말의 사진으로, 화학물질을 가하여 로스팅할 경우 새싹보리의 엽록소가 안정화되어 균일하고 고운 분말을 제조할 수 있다. 즉 순수하게 새싹보리를 건조할 경우에는 입감이 비리할 수 있으므로 입감을 높이기 위해서 첨가물을 사용할 수 있다. 이때 첨가물로서 천일염을 배합비 1% 이하로 하고 85℃ 물에서 30초 이하로 브렌칭하여 로스팅하였다. As another embodiment, it is a photograph of a powder obtained by grinding a bud of barley powder with a chemical added to a roasted barley and grinding it to a particle size different from that of the roasted barley powder. When roasting with a chemical substance, the chlorophyll of the roasted barley is stabilized, Fine powder can be produced. In other words, when pure dried barley is used, additives may be used to increase the sensation because the sensation may be irritating. At this time, the mixture was roasted at 85 ° C for 30 seconds or less with blending ratio of 1% or less.
새싹보리 분말의 입자크기는 1 내지 500 ㎛ 사이에 분포하며 주로 100 ㎛ 전후로 분포하지만, 라떼용 새싹보리분말의 입도분포는 1 내지 100㎛ 사이에 분포하며 10 ㎛ 전후의 입자가 가장 많이 존재하였다. The grain size of shoot barley powder was distributed between 1 and 500 ㎛ and distributed mainly around 100 ㎛. However, the grain size distribution of latte barley powder was distributed between 1 and 100 ㎛ and most of the particles were around 10 ㎛.
Claims (2)
상기 새싹보리분말은 새싹보리를 로스팅 또는 저온건조 후 그라인딩된 것을 특징으로 하는 프리믹스 조성물.The method according to claim 1,
Wherein the germanium barley powder is roasted or low temperature dried and then ground.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160082971A KR20180003316A (en) | 2016-06-30 | 2016-06-30 | A method of preparing beverage using young barley leaves and beverage prepared therefrom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160082971A KR20180003316A (en) | 2016-06-30 | 2016-06-30 | A method of preparing beverage using young barley leaves and beverage prepared therefrom |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20180003316A true KR20180003316A (en) | 2018-01-09 |
Family
ID=61000664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160082971A KR20180003316A (en) | 2016-06-30 | 2016-06-30 | A method of preparing beverage using young barley leaves and beverage prepared therefrom |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20180003316A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102118697B1 (en) * | 2019-11-06 | 2020-06-03 | (주)에스앤피인터내셔널 | Manufacturing method of sprout barley juice powder and sprout barley juice powder mixing compound therof |
CN112889920A (en) * | 2019-12-03 | 2021-06-04 | 内蒙古蒙牛乳业(集团)股份有限公司 | Stabilizer suitable for non-whole milk products, milk products made therefrom and preparation method thereof |
KR20210155500A (en) * | 2020-06-16 | 2021-12-23 | 주식회사 피엔에스 | Powder yogurt containing barley sprouts and making method of the same |
KR20230046602A (en) | 2021-09-30 | 2023-04-06 | (주)리너지 | smart Fried-crumbs dustbin and System thereof |
-
2016
- 2016-06-30 KR KR1020160082971A patent/KR20180003316A/en not_active Application Discontinuation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102118697B1 (en) * | 2019-11-06 | 2020-06-03 | (주)에스앤피인터내셔널 | Manufacturing method of sprout barley juice powder and sprout barley juice powder mixing compound therof |
CN112889920A (en) * | 2019-12-03 | 2021-06-04 | 内蒙古蒙牛乳业(集团)股份有限公司 | Stabilizer suitable for non-whole milk products, milk products made therefrom and preparation method thereof |
KR20210155500A (en) * | 2020-06-16 | 2021-12-23 | 주식회사 피엔에스 | Powder yogurt containing barley sprouts and making method of the same |
KR20230046602A (en) | 2021-09-30 | 2023-04-06 | (주)리너지 | smart Fried-crumbs dustbin and System thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104687061B (en) | A kind of health care's ice powder and preparation method thereof and a kind of preparation method of ice powder powder | |
TWI307620B (en) | ||
KR101612813B1 (en) | Manufacturing method of fermented salt containing ginseng steaed red juice | |
KR20180003316A (en) | A method of preparing beverage using young barley leaves and beverage prepared therefrom | |
WO2006132042A1 (en) | Nutritional supplement powder and fat for food or medicine | |
KR101632794B1 (en) | METHOD OF MANUFACTURING PILL COMPRISED OF Protaetia brevitarsis seulensis | |
KR20170036886A (en) | A method of preparing beverage using pear, stone cell and strawberry | |
CN107173770A (en) | A kind of ginkgo nutritional sauce and preparation method thereof | |
KR20120095595A (en) | Method of preparing fattune liquid comprising onion and grapefruit | |
KR20170036844A (en) | Method for manufacturing drink including peanut sprout extracts | |
KR101384831B1 (en) | A process for preparing beverage containing flower, inner skin and pulp of a chestnut and a beverage thereof | |
KR101702014B1 (en) | Composition of Food for relief of alcoholic hangover and preparation method thereof | |
CN105795279A (en) | Food beverage formula for human nutrition dietetic invigoration | |
KR101037572B1 (en) | Powder manufacturing process using rind and pip of rubus coreanus | |
KR101622767B1 (en) | Method for Manufacturing Sauce for spiced rib Using dietary Fiber | |
KR20150012720A (en) | Using rose petals, rose syrup, rose, red pepper, rose petals snack and take advantage of the various methods and the composition of the nutrient composition of foods | |
JP2001275587A (en) | Method of extracting propolis and food including the same | |
KR101654098B1 (en) | Method for producing Vitis coignetiae vitamin candy and Vitis coignetiae vitamin candy produced by the same method | |
CN106804810A (en) | A kind of catchweed bedstraw herb heat-clearing and detoxicating tea jelly and preparation method thereof | |
CN105265974A (en) | Almond flavored tartary buckwheat beverage and preparation method thereof | |
KR20160076014A (en) | Method of preparing functional beverage | |
RU2457712C1 (en) | Composition for preparation of medical and preventive beverages and purees | |
KR101991359B1 (en) | A method of preparing pear beverage using apple | |
JP2007246449A (en) | Lipolysis promoter and food, drink and feed each containing the same | |
CN104256026A (en) | Blood-pressure-reducing coffee |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |